U.S. flag

An official website of the United States government

t(X;9)(q23;q12)dn AND Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Mar 1, 2016
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000727550.2

Allele description [Variation Report for t(X;9)(q23;q12)dn]

t(X;9)(q23;q12)dn

Gene:
AMMECR1:AMMECR nuclear protein 1 [Gene - OMIM - HGNC]
Variant type:
Translocation
Cytogenetic location:
Xq23
Preferred name:
t(X;9)(q23;q12)dn

Condition(s)

Name:
Midface hypoplasia, hearing impairment, elliptocytosis, and nephrocalcinosis (MFHIEN)
Identifiers:
MONDO: MONDO:0010516; MedGen: C4310810; OMIM: 300990

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000854429Genetics Division, Universidade Federal de Sao Paulo
no assertion criteria provided
Likely pathogenic
(Mar 1, 2016)
de novoresearch

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
Braziliande novoyes1not providednot providednot providednot providedresearch

Details of each submission

From Genetics Division, Universidade Federal de Sao Paulo, SCV000854429.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1Brazilian1not providednot providedresearchnot provided

Description

We report five individuals with loss-of-function of the X-linked AMMECR1: a girl with a balanced X-autosome translocation and inactivation of the normal X-chromosome; two boys with maternally-inherited and de novo nonsense variants; and two half-brothers with maternally inherited microdeletion variants. They present with short stature, cardiac and skeletal abnormalities and hearing loss. Variants of unknown significance in AMMECR1 in four male patients from two families with partially overlapping phenotypes were previously reported. AMMECR1 is co-expressed with genes implicated in cell cycle regulation, five of which were previously associated with growth and bone alteration syndromes. Our knockdown of the zebrafish orthologous gene resulted in phenotypes reminiscent of patients’ features. The increased transcript and encoded protein levels of AMMECR1L, an AMMECR1 paralog, in the t(X;9) patient’s cells indicate a partial compensatory mechanism. AMMECR1 and AMMECR1L proteins dimerize and localize to the nucleus as suggested by their nucleic acid-binding RAGNYA folds. Our results suggest that AMMECR1 is potentially involved in cell cycle control and linked to a new syndrome with growth, bone, heart and kidney alterations and elliptocytosis.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1de novoyesnot providednot providednot provided1not providednot providednot provided

Last Updated: Jun 23, 2024